Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology

Chronic myelogenous leukemia (CML) is a malignancy of the myeloid cell lineage characterized by a recurrent chromosomal abnormality: the Philadelphia chromosome, which results from the reciprocal translocation of the chromosomes 9 and 22. The Philadelphia chromosome contains a fusion gene called BCR...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Oncol
Autors principals: Moisoiu, Vlad, Teodorescu, Patric, Parajdi, Lorand, Pasca, Sergiu, Zdrenghea, Mihnea, Dima, Delia, Precup, Radu, Tomuleasa, Ciprian, Soverini, Simona
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6768007/
https://ncbi.nlm.nih.gov/pubmed/31608223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00863
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars